|
|
||||||||
The Journal of Immunology, Vol 154, Issue 8 4123-4132, Copyright © 1995 by American Association of Immunologists
ARTICLES |
WS Powell, D Chung and S Gravel
Meakins-Christie Laboratories, Department of Medicine, McGill University, Montreal, Quebec, Canada.
Human neutrophils and monocytes contain a highly specific dehydrogenase which converts 5-hydroxy-6,8,11,14-eicosatetraenoic acid (5-HETE) to 5- oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE). We have previously shown that 5-oxo-ETE is a potent stimulus of neutrophil calcium levels and migration and have now investigated its effects on human eosinophils. 5-Oxo-ETE is a potent stimulus of eosinophil migration, with significant effects being detected at concentrations as low as 1 nM and a maximal response at 1 microM. The responses elicited by 5-oxo- ETE were about two to three times greater than those to platelet- activating factor (PAF) and 5-oxo-15-hydroxy-6,8,11,13-eicosatetraenoic acid (5-oxo-15-hydroxy-ETE) at all concentrations tested between 10 nM and 1 microM. Leukotrienes B4 and D4 also significantly stimulated eosinophil migration, but the maximal responses to these agonists were only about 4% of the maximal response to 5-oxo-ETE. A low concentration of 5-oxo-ETE (1 nM) potentiated eosinophil migration in response to PAF. Eosinophils were capable of converting 5-HETE to 5-oxo-ETE, and this reaction was enhanced by phorbol myristate acetate. Stimulation of eosinophils with A23187 in the presence of low concentrations of arachidonic acid and phorbol 12-myristate 13-acetate led to the formation of 5-oxo-ETE and 5-oxo-15-hydroxy-ETE, but the amounts were considerably less than those of other eicosanoids such as leukotriene C4, cysteine-containing lipoxins, and 5,15-dihydroxy-6E,8Z,11Z,13E- eicosatetraenoic acid. In summary, of all the lipid mediators tested, 5- oxo-ETE was the most effective in stimulating migration of human eosinophils. Although eosinophils are capable of synthesizing 5-oxo- eicosanoids, the amounts detected were relatively small, and other leukocytes such as neutrophils, monocytes, or macrophages may be more important sites for the synthesis of this compound.
This article has been cited by other articles:
![]() |
P. Patel, C. Cossette, J. R. Anumolu, S. Gravel, A. Lesimple, O. A. Mamer, J. Rokach, and W. S. Powell Structural Requirements for Activation of the 5-Oxo-6E,8Z, 11Z,14Z-eicosatetraenoic Acid (5-Oxo-ETE) Receptor: Identification of a Mead Acid Metabolite with Potent Agonist Activity J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 698 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Cormier, A. G. Taranova, C. Bedient, T. Nguyen, C. Protheroe, R. Pero, D. Dimina, S. I. Ochkur, K. O'Neill, D. Colbert, et al. Pivotal Advance: Eosinophil infiltration of solid tumors is an early and persistent inflammatory host response J. Leukoc. Biol., June 1, 2006; 79(6): 1131 - 1139. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Koike, H. Obinata, A. Yamamoto, S. Takeda, H. Komori, F. Nara, T. Izumi, and T. Haga 5-Oxo-Eicosatetraenoic Acid-Induced Chemotaxis: Identification of a Responsible Receptor hGPCR48 and Negative Regulation by G Protein G12/13. J. Biochem., March 1, 2006; 139(3): 543 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Almishri, C. Cossette, J. Rokach, J. G. Martin, Q. Hamid, and W. S. Powell Effects of Prostaglandin D2, 15-Deoxy-{Delta}12,14-prostaglandin J2, and Selective DP1 and DP2 Receptor Agonists on Pulmonary Infiltration of Eosinophils in Brown Norway Rats J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 64 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Monneret, R. Boumiza, S. Gravel, C. Cossette, J. Bienvenu, J. Rokach, and W. S. Powell Effects of Prostaglandin D2 and 5-Lipoxygenase Products on the Expression of CD203c and CD11b by Basophils J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 627 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Oka, S. Ikeda, S. Kishimoto, M. Gokoh, S. Yanagimoto, K. Waku, and T. Sugiura 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils J. Leukoc. Biol., November 1, 2004; 76(5): 1002 - 1009. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mercier, C. Morin, M. Cloutier, S. Proteau, J. Rokach, W. S. Powell, and E. Rousseau 5-Oxo-ETE regulates tone of guinea pig airway smooth muscle via activation of Ca2+ pools and Rho-kinase pathway Am J Physiol Lung Cell Mol Physiol, October 1, 2004; 287(4): L631 - L640. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-R. Erlemann, J. Rokach, and W. S. Powell Oxidative Stress Stimulates the Synthesis of the Eosinophil Chemoattractant 5-Oxo-6,8,11,14-eicosatetraenoic Acid by Inflammatory Cells J. Biol. Chem., September 24, 2004; 279(39): 40376 - 40384. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Stamatiou, C.-C. Chan, G. Monneret, D. Ethier, J. Rokach, and W. S. Powell 5-Oxo-6,8,11,14-eicosatetraenoic Acid Stimulates the Release of the Eosinophil Survival Factor Granulocyte/Macrophage Colony-stimulating Factor from Monocytes J. Biol. Chem., July 2, 2004; 279(27): 28159 - 28164. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Mrsny, A. T. Gewirtz, D. Siccardi, T. Savidge, B. P. Hurley, J. L. Madara, and B. A. McCormick From The Cover: Identification of hepoxilin A3 in inflammatory events: A required role in neutrophil migration across intestinal epithelia PNAS, May 11, 2004; 101(19): 7421 - 7426. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Brink, S.-E. Dahlen, J. Drazen, J. F. Evans, D. W. P. Hay, G. E. Rovati, C. N. Serhan, T. Shimizu, and T. Yokomizo International Union of Pharmacology XLIV. Nomenclature for the Oxoeicosanoid Receptor Pharmacol. Rev., March 1, 2004; 56(1): 149 - 157. [Abstract] [Full Text] [PDF] |
||||
![]() |
M-J. Dallaire, C. Ferland, N. Page, S. Lavigne, F. Davoine, and M. Laviolette Endothelial cells modulate eosinophil surface markers and mediator release Eur. Respir. J., June 1, 2003; 21(6): 918 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zarini and R. C. Murphy Biosynthesis of 5-Oxo-6,8,11,14-eicosatetraenoic Acid from 5-Hydroperoxyeicosatetraenoic Acid in the Murine Macrophage J. Biol. Chem., March 21, 2003; 278(13): 11190 - 11196. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Jones, S. Holden, L. Tenaillon, U. Bhatia, K. Seuwen, P. Tranter, J. Turner, R. Kettle, R. Bouhelal, S. Charlton, et al. Expression and Characterization of a 5-oxo-6E,8Z,11Z,14Z-Eicosatetraenoic Acid Receptor Highly Expressed on Human Eosinophils and Neutrophils Mol. Pharmacol., March 1, 2003; 63(3): 471 - 477. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Monneret, C. Cossette, S. Gravel, J. Rokach, and W. S. Powell 15R-Methyl-Prostaglandin D2 Is a Potent and Selective CRTH2/DP2 Receptor Agonist in Human Eosinophils J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 349 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Monneret, H. Li, J. Vasilescu, J. Rokach, and W. S. Powell 15-Deoxy-{Delta}12,1412,14-prostaglandins D2 and J2 Are Potent Activators of Human Eosinophils J. Immunol., April 1, 2002; 168(7): 3563 - 3569. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Monneret, S. Gravel, M. Diamond, J. Rokach, and W. S. Powell Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor Blood, September 15, 2001; 98(6): 1942 - 1948. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Boden, S. Schweizer, T. Bertsche, M. Dufer, G. Drews, and H. Safayhi Stimulation of Leukotriene Synthesis in Intact Polymorphonuclear Cells by the 5-Lipoxygenase Inhibitor 3-oxo-Tirucallic Acid Mol. Pharmacol., August 1, 2001; 60(2): 267 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ferland, M. Guilbert, F. Davoine, N. Flamand, J. Chakir, and M. Laviolette Eotaxin promotes eosinophil transmigration via the activation of the plasminogen-plasmin system J. Leukoc. Biol., May 1, 2001; 69(5): 772 - 778. [Abstract] [Full Text] |
||||
![]() |
J. M. Hevko, R. C. Bowers, and R. C. Murphy Synthesis of 5-Oxo-6,8,11,14-eicosatetraenoic Acid and Identification of Novel omega -Oxidized Metabolites in the Mouse Macrophage J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 293 - 305. [Abstract] [Full Text] |
||||
![]() |
T. Urasaki, J. Takasaki, T. Nagasawa, and H. Ninomiya Pivotal role of 5-lipoxygenase in the activation of human eosinophils: platelet-activating factor and interleukin-5 induce CD69 on eosinophils through the 5-lipoxygenase pathway J. Leukoc. Biol., January 1, 2001; 69(1): 105 - 112. [Abstract] [Full Text] |
||||
![]() |
F. Rose, L. Kiss, F. Grimminger, K. Mayer, U. Grandel, W. Seeger, E. Bieniek, and U. Sibelius E. coli hemolysin-induced lipid mediator metabolism in alveolar macrophages: impact of eicosapentaenoic acid Am J Physiol Lung Cell Mol Physiol, July 1, 2000; 279(1): L100 - L109. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. O'Flaherty, J. S. Taylor, and M. Kuroki The Coupling of 5-Oxo-Eicosanoid Receptors to Heterotrimeric G Proteins J. Immunol., March 15, 2000; 164(6): 3345 - 3352. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. MacLeod, P. Lembessis, J. R. Hamilton, and W. S. Powell 5-Oxo-6,8,11,14-eicosatetraenoic Acid Stimulates Isotonic Volume Reduction of Guinea Pig Jejunal Crypt Epithelial Cells J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 511 - 516. [Abstract] [Full Text] |
||||
![]() |
M. Guilbert, C. Ferland, M. Bossé, N. Flamand, S. Lavigne, and M. Laviolette 5-Oxo-6,8,11,14-Eicosatetraenoic Acid Induces Important Eosinophil Transmigration through Basement Membrane Components . Comparison of Normal and Asthmatic Eosinophils Am. J. Respir. Cell Mol. Biol., July 1, 1999; 21(1): 97 - 104. [Abstract] [Full Text] |
||||
![]() |
M. A. Giembycz and M. A. Lindsay Pharmacology of the Eosinophil Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Janabi, I. Hau, and M. Tardieu Negative Feedback Between Prostaglandin and {alpha}- and {beta}-Chemokine Synthesis in Human Microglial Cells and Astrocytes J. Immunol., February 1, 1999; 162(3): 1701 - 1706. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Powell, S. Gravel, S. P. Khanapure, and J. Rokach Biological Inactivation of 5-oxo-6,8,11,14-Eicosatetraenoic Acid by Human Platelets Blood, February 1, 1999; 93(3): 1086 - 1096. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Powell, S. Gravel, and F. Halwani 5-oxo-6,8,11,14-Eicosatetraenoic Acid Is a Potent Stimulator of L-Selectin Shedding, Surface Expression of CD11b, Actin Polymerization, and Calcium Mobilization in Human Eosinophils Am. J. Respir. Cell Mol. Biol., January 1, 1999; 20(1): 163 - 170. [Abstract] [Full Text] |
||||
![]() |
J. T. O'Flaherty, J. S. Taylor, and M. J. Thomas Receptors for the 5-Oxo Class of Eicosanoids in Neutrophils J. Biol. Chem., December 4, 1998; 273(49): 32535 - 32541. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Berhane, A. A. Ray, S. P. Khanapure, J. Rokach, and W. S. Powell Calcium/Calmodulin-dependent Conversion of 5-Oxoeicosanoids to 6,7-Dihydro Metabolites by a Cytosolic Olefin Reductase in Human Neutrophils J. Biol. Chem., August 14, 1998; 273(33): 20951 - 20959. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dunzendorfer, P. Schratzberger, N. Reinisch, C. M. Kahler, and C. J. Wiedermann Secretoneurin, a Novel Neuropeptide, Is a Potent Chemoattractant for Human Eosinophils Blood, March 1, 1998; 91(5): 1527 - 1532. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. O'Flaherty, M. Kuroki, A. B. Nixon, J. Wijkander, E. Yee, S. L. Lee, P. K. Smitherman, R. L. Wykle, and L. W. Daniel 5-Oxo-eicosanoids and Hematopoietic Cytokines Cooperate in Stimulating Neutrophil Function and the Mitogen-activated Protein Kinase Pathway J. Biol. Chem., July 26, 1996; 271(30): 17821 - 17828. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |